# Administration of AdVEGF-All6A+ to Myocardium of Individuals With Diffuse CAD Via Minimally Invasive Surgery

> **NCT01757223** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Weill Medical College of Cornell University**

## Conditions studied

- Coronary Artery Disease

## Interventions

- **BIOLOGICAL:** AdVEGF-All6A+
- **BIOLOGICAL:** AdNull

## Key facts

- **NCT ID:** NCT01757223
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-12
- **Primary completion:** 2030-10
- **Final completion:** 2030-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Closure due to lack of funding.
- **Last updated:** 2021-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01757223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01757223, "Administration of AdVEGF-All6A+ to Myocardium of Individuals With Diffuse CAD Via Minimally Invasive Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01757223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*